Oxetorone: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{XXXXX}}
{{CMG}}; {{AE}} {{PB}}
'''''For patient information about Oxetorone, click [[Oxetorone (patient information)|here]].'''''
{{SB}} <sup>®</sup>,
==Overview==
{{Drugbox
| verifiedrevid = 444750715
| IUPAC_name = (3''Z'')-3-[1]benzofuro[3,2-''c''][1]benzoxepin-6(12''H'')-ylidene-''N,N''-dimethylpropan-1-amine
| image = Oxetorone.png
| width = 180
| alt = Ball-and-stick model
| image2 = Oxetorone-3D-balls.png
| alt2 = Ball-and-stick model
<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|international|oxetorone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 26020-55-3
| ATC_prefix = N02
| ATC_suffix = CX06
| PubChem = 6436540
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = T3XOS33TIQ
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08312
<!--Chemical data-->
| chemical_formula =
| C=21 | H=21 | N=1 | O=2
| molecular_weight = 319.40 g/mol
| smiles = CN(C)CCC=C1C2=CC=CC=C2OCC3=C1OC4=CC=CC=C34
}}
'''Oxetorone''' is an [[antimigraine]] agent.<ref name="pmid11139754">{{cite journal |author=Massiou H |title=[Prophylactic treatments of migraine] |language=French |journal=Rev. Neurol. (Paris) |volume=156 Suppl 4 |issue= |pages=4S79–86 |year=2000 |pmid=11139754 |doi= |url=http://www.masson.fr/masson/79997}}</ref>
Association with [[hyperprolactinemia]] has been described.<ref name="pmid8980859">{{cite journal |author=Pradalier A |title=Hyperprolactinaemia and depression induced by oxetorone |journal=Cephalalgia |volume=16 |issue=8 |pages=560–1 |date=December 1996 |pmid=8980859 |doi= 10.1046/j.1468-2982.1996.1608560.x|url=http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0333-1024&date=1996&volume=16&issue=8&spage=560}}</ref>
<ref>{{Cite web  | last =  | first =  | title = Oxetorone - Wikipedia, the free encyclopedia | url = http://en.wikipedia.org/wiki/Oxetorone | publisher =  | date =  | accessdate =  }}</ref>  Normal  0          false  false  false    EN-US  X-NONE  X-NONE                                                                                                                                                                                                                                                                                                                                                           
==References==
{{Reflist|2}}
[[Antimigraine preparations]]
[[Category:Drugs]]

Revision as of 18:39, 12 February 2014


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about Oxetorone, click here.

Synonyms / Brand Names: ®,

Overview

Oxetorone
Ball-and-stick model
Ball-and-stick model
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC21H21NO2
Molar mass319.40 g/mol
3D model (JSmol)
  (verify)

Oxetorone is an antimigraine agent.[1]

Association with hyperprolactinemia has been described.[2] 

[3]   Normal  0          false  false  false    EN-US  X-NONE  X-NONE

References

  1. ↑ Massiou H (2000). "[Prophylactic treatments of migraine]". Rev. Neurol. (Paris) (in French). 156 Suppl 4: 4S79–86. PMID 11139754.
  2. ↑ Pradalier A (December 1996). "Hyperprolactinaemia and depression induced by oxetorone". Cephalalgia. 16 (8): 560–1. doi:10.1046/j.1468-2982.1996.1608560.x. PMID 8980859.
  3. ↑ "Oxetorone - Wikipedia, the free encyclopedia".

Antimigraine preparations

Retrieved from "https://www.wikidoc.org/index.php?title=Oxetorone&oldid=942743"